Pharmaceuticals, Biotechnology and Life Sciences
Piramal Pharma Solutions has said it plans to expand its facility in Riverview, Michigan, for which it will invest approximately $32 Million to add capacity and new capabilities in potent and non-potent API development and manufacturing.
Piramal Pharma Solutions (PPS), has invested $10 million for a new wing at the Riverview site dedicated to the production of high potency active pharmaceutical ingredients (HPAPIs) with low Occupational Exposure Levels (OELs).
Contract Development and Manufacturing Organization (CDMO) Piramal Pharma Solutions (PPS), has invested $55 million across its sites in North America…
Piramal Pharma Solutions (PPS), part of Piramal Enterprises Limited, has appointed John Fowler as its Chief Operating Officer last week. Fowler…